Open AccessDrug Lag for Inflammatory Bowel Disease Treatments in the East and West
Author(s) -
Shinji Okabayashi,
Taku Kobayashi,
Toshifumi Hibi∥
Publication year - 2018
Publication title -
inflammatory intestinal diseases
Language(s) - English
Resource type - Journals
eISSN - 2296-9403
pISSN - 2296-9365
DOI - 10.1159/000491878
Subject(s) - ulcerative colitis , medicine , inflammatory bowel disease , drug , european union , disease , lag time , pharmacology , biology , biological system , business , economic policy
Inflammatory bowel disease (IBD), though historically common in the West, is now increasingly prevalent in industrializing countries. A simultaneous dramatic increase in IBD drug options has enabled most patients to achieve remission. Nevertheless, worldwide disparities in the approval of IBD drugs, or "drug lag", remain problematic.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom